Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Gene Mutation
100%
CARD11
100%
KMT2A
100%
S1PR1
100%
Cyclin Dependent Kinase Inhibitor 2A
100%
Next Generation Sequencing
50%
Mutation Rate
50%
Prevalence
50%
Cytogenetics
50%
TLR2
50%
Mutated Genes
50%
TRAF2
50%
CHD2
50%
Keyphrases
Meta-analysis
100%
Genetic mutation
100%
Genetic Features
100%
Mantle Cell Lymphoma
100%
Cyclin D1 (CCND1)
20%
Tumor Protein p53 (TP53)
20%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
20%
Sphingosine-1-phosphate Receptor (S1PR)
20%
Patient-level Data
20%
Lymphoma Patients
20%
CARD11
20%
NSD2
20%
KMT2A
20%
Tumor
10%
Mutation Frequency
10%
Disease Progression
10%
Non-Hodgkin Lymphoma
10%
Aberrations
10%
Serial Sampling
10%
Therapeutic Response
10%
Metagenomic Next-generation Sequencing (mNGS)
10%
Mutant Frequency
10%
Multiple Regression Model
10%
Mutational Status
10%
Cytogenetic Techniques
10%
Notch2
10%
Chemotherapy Resistance
10%
Frequency Difference
10%
Bone Marrow Samples
10%
Significantly mutated Genes
10%
Mutational Landscape
10%
Rare Subtype
10%
RIP140
10%
ARID2
10%
Molecular Aberrations
10%
RIMS2
10%
Baseline mutations
10%
TRAF2
10%
CHD2
10%
Precision Medicine Initiative
10%
Ten-eleven Translocation 1 (TET1)
10%
Working Diagnosis
10%
TLR2
10%